Zafgen Reports First Quarter 2018 Operating and Financial Results
May 08, 2018 20:05 pm UTC| Business
Multiple ZGN-1061 abstracts accepted for presentation at upcoming American Diabetes Association (ADA) Scientific Sessions ZGN-1061 Phase 1 SAD / MAD data published in Diabetes, Obesity and Metabolism BOSTON, May 08,...
Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update
May 08, 2018 20:05 pm UTC| Business
MENLO PARK, Calif., May 08, 2018 -- Corcept Therapeutics Incorporated (NASDAQ:CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic and psychiatric...
May 08, 2018 20:05 pm UTC| Business
EL SEGUNDO, Calif., May 08, 2018 -- A-Mark Precious Metals, Inc. (NASDAQ:AMRK), a full-service precious metals trading company and an official distributor for all the major sovereign mints, reported results for the...
Bojangles’, Inc. Reports Financial Results for its First Fiscal Quarter 2018
May 08, 2018 20:05 pm UTC| Business
CHARLOTTE, N.C., May 08, 2018 -- Bojangles’, Inc. (Bojangles’) (NASDAQ:BOJA) today announced financial results for the 13-week first fiscal quarter ended April 1, 2018. Bojangles’ also reiterated its annual guidance for...
Extraction Oil & Gas, Inc. Announces First-Quarter 2018 Results
May 08, 2018 20:04 pm UTC| Business
DENVER, May 08, 2018 -- Extraction Oil Gas, Inc. (NASDAQ:XOG) (“Extraction” or the “Company”) today reported financial and operational results for the first quarter of 2018. First-Quarter 2018 Highlights First...
OSS Reports First Quarter 2018 Results: Revenue up 12% to $7.1 Million; Reiterates 2018 Guidance
May 08, 2018 20:04 pm UTC| Business
ESCONDIDO, Calif., May 08, 2018 -- OSS (NASDAQ:OSS), a leading provider of high performance computing systems, reported results for the quarter ended March 31, 2018 and reiterates its guidance for 2018. Financial...
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 08, 2018 20:03 pm UTC| Business
MENLO PARK, Calif., May 08, 2018 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of...